Efficacy and safety of olanzapine in the treatment of patients with bipolar I disorder, depressed: a randomized, double-blind comparison with placebo.

Trial Profile

Efficacy and safety of olanzapine in the treatment of patients with bipolar I disorder, depressed: a randomized, double-blind comparison with placebo.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Aug 2012

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Bipolar I disorders
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Aug 2012 Results published in the British Journal of Psychiatry.
    • 12 Aug 2010 Actual end date (July 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top